SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unitedhealth Group Inc – ‘10-Q’ for 6/30/16 – ‘ZIP’

On:  Tuesday, 8/2/16, at 4:37pm ET   ·   For:  6/30/16   ·   Accession #:  731766-16-81   ·   File #:  1-10864

Previous ‘10-Q’:  ‘10-Q’ on 5/4/16 for 3/31/16   ·   Next:  ‘10-Q’ on 11/8/16 for 9/30/16   ·   Latest:  ‘10-Q’ on 5/9/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/02/16  Unitedhealth Group Inc            10-Q        6/30/16   60:10M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    751K 
 2: EX-10.1     Material Contract                                   HTML     61K 
 3: EX-10.2     Material Contract                                   HTML     26K 
 4: EX-12.1     Statement re: Computation of Ratios                 HTML     29K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     34K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
13: R1          Document and Entity Information Document            HTML     37K 
14: R2          Condensed Consolidated Balance Sheets               HTML    118K 
15: R3          Condensed Consolidated Balance Sheet                HTML     35K 
                (Parenthetical)                                                  
16: R4          Condensed Consolidated Statements of Operations     HTML     89K 
17: R5          Condensed Consolidated Statements of Comprehensive  HTML     57K 
                Income                                                           
18: R6          Condensed Consolidated Statements of Changes in     HTML     86K 
                Equity                                                           
19: R7          Condensed Consolidated Statements of Cash Flows     HTML    109K 
20: R8          Basis of Presentation (Notes)                       HTML     35K 
21: R9          Investments (Notes)                                 HTML    243K 
22: R10         Fair Value (Notes)                                  HTML    244K 
23: R11         Medicare Part D Pharmacy Benefits (Notes)           HTML     36K 
24: R12         Other Current Receivables (Notes)                   HTML     21K 
25: R13         Medical Costs Reserve Development (Notes)           HTML     32K 
26: R14         Commercial Paper and Long-Term Debt (Notes)         HTML    200K 
27: R15         Shareholders' Equity (Notes)                        HTML     34K 
28: R16         Commitments and Contingencies (Notes)               HTML     33K 
29: R17         Segment Financial Information (Notes)               HTML    317K 
30: R18         Basis of Presentation (Policies)                    HTML     41K 
31: R19         Investments (Tables)                                HTML    242K 
32: R20         Fair Value (Tables)                                 HTML    245K 
33: R21         Medicare Part D Pharmacy Benefits (Tables)          HTML     33K 
34: R22         Medical Costs Reserve Development (Tables)          HTML     32K 
35: R23         Commercial Paper and Long-Term Debt (Tables)        HTML    198K 
36: R24         Shareholders' Equity (Tables)                       HTML     26K 
37: R25         Segment Financial Information (Tables)              HTML    313K 
38: R26         Basis of Presentation Basis of Presentation, Uses   HTML     36K 
                of Estimates and Significant Accounting Policies                 
                (Details)                                                        
39: R27         Investments (Narrative) (Details)                   HTML     23K 
40: R28         Investments (Short-Term and Long-Term Investments)  HTML     85K 
                (Details)                                                        
41: R29         Investments (Amortized Cost and Fair Value of       HTML     93K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
42: R30         Investments (Fair Value of Available-For-Sale       HTML     61K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
43: R31         Investments (Net Realized Gains) (Details)          HTML     38K 
44: R32         Fair Value (Narrative) (Details)                    HTML     36K 
45: R33         Fair Value (Financial Assets and Liabilities,       HTML     85K 
                Excluding AARP, Measured at Fair Value on a                      
                Recurring Basis) (Details)                                       
46: R34         Fair Value (Financial Assets and Liabilities,       HTML     83K 
                Excluding AARP, Not Measured at Fair Value on a                  
                Recurring Basis) (Details)                                       
47: R35         Fair Value (Reconciliation of Assets Measured at    HTML     43K 
                Fair Value on a Recurring Basis Using Level 3                    
                Inputs) (Details)                                                
48: R36         Medicare Part D Pharmacy Benefits Schedule of       HTML     27K 
                Receivables and Payables (Details)                               
49: R37         Other Current Receivables (Details)                 HTML     22K 
50: R38         Medical Costs Reserve Development (Details)         HTML     23K 
51: R39         Commercial Paper and Long-Term Debt (Narrative)     HTML     67K 
                (Details)                                                        
52: R40         Commercial Paper and Long-Term Debt (Details)       HTML    173K 
53: R41         Shareholders' Equity (Details)                      HTML     19K 
54: R42         Shareholders' Equity Dividends Paid (Details)       HTML     22K 
55: R43         Commitments and Contingencies (Details)             HTML     33K 
56: R44         Segment Financial Information (Narrative)           HTML     20K 
                (Details)                                                        
57: R45         Segment Financial Information (Details)             HTML     99K 
59: XML         IDEA XML File -- Filing Summary                      XML    103K 
58: EXCEL       IDEA Workbook of Financial Reports                  XLSX     69K 
 7: EX-101.INS  XBRL Instance -- unh-20160630                        XML   4.07M 
 9: EX-101.CAL  XBRL Calculations -- unh-20160630_cal                XML    195K 
10: EX-101.DEF  XBRL Definitions -- unh-20160630_def                 XML    632K 
11: EX-101.LAB  XBRL Labels -- unh-20160630_lab                      XML   1.39M 
12: EX-101.PRE  XBRL Presentations -- unh-20160630_pre               XML    798K 
 8: EX-101.SCH  XBRL Schema -- unh-20160630                          XSD    142K 
60: ZIP         XBRL Zipped Folder -- 0000731766-16-000081-xbrl      Zip    230K 


‘ZIP’   —   XBRL Zipped Folder — 0000731766-16-000081-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:unh-20160630.xml
unh-20160630.xsd
unh-20160630_cal.xml
unh-20160630_def.xml
unh-20160630_lab.xml
unh-20160630_pre.xml


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  UnitedHealth Group Inc.           10-K       12/31/23  119:19M
 2/24/23  UnitedHealth Group Inc.           10-K       12/31/22  119:19M
 2/15/22  UnitedHealth Group Inc.           10-K       12/31/21  113:19M
 3/01/21  UnitedHealth Group Inc.           10-K       12/31/20  107:17M
Top
Filing Submission 0000731766-16-000081   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 12:24:48.1pm ET